Maximilian de Courten
Overview
Explore the profile of Maximilian de Courten including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
1829
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Saadati S, Jansons P, Scott D, de Courten M, Mousa A, Feehan J, et al.
Nutrients
. 2025 Jan;
16(24.
PMID: 39770949
Background/objectives: Type 2 diabetes (T2D) is associated with an increased risk of adverse musculoskeletal outcomes likely due to heightened chronic inflammation, oxidative stress, and advanced glycation end-products (AGE). Carnosine has...
2.
Iyngkaran P, Smith D, McLachlan C, Battersby M, de Courten M, Hanna F
J Clin Med
. 2024 Dec;
13(23).
PMID: 39685832
Congestive heart failure (CHF) is a complex chronic disease, and it is associated with a second comorbid condition in more than half of cases. Self-management programs can be specific to...
3.
Saadati S, de Courten M, Deceneux C, Plebanski M, Scott D, Mesinovic J, et al.
Nutrients
. 2024 Nov;
16(22).
PMID: 39599686
Background/objectives: In vitro studies suggest that carnosine reduces inflammation by upregulating anti-inflammatory mediators and downregulating pro-inflammatory cytokines. However, human clinical trials examining the effects of carnosine on inflammatory biomarkers are...
4.
Iyngkaran P, Smith D, McLachlan C, Battersby M, de Courten M, Hanna F
J Clin Med
. 2024 Nov;
13(22).
PMID: 39598138
Heart failure (HF) is a complex syndrome, with multiple causes. Numerous pathophysiological pathways are activated. Comprehensive and guideline-derived care is complex. A multidisciplinary approach is required. The current guidelines report...
5.
Dash S, McNamara S, de Courten M, Calder R
Front Public Health
. 2024 Jul;
12:1396614.
PMID: 39035182
This rapid review delves into the realm of social prescribing as a novel approach to suicide prevention by addressing the social determinants of health. Through an exploration of various databases...
6.
Usmani W, de Courten M, Hanna F
Front Oral Health
. 2024 Jun;
5:1364765.
PMID: 38846319
Background: Cardiovascular diseases (CVDs) are a significant cause of morbidity and mortality worldwide, resulting in a high socioeconomic burden. Growing evidence has shown a link between oral diseases and several...
7.
Iyngkaran P, Buhler M, de Courten M, Hanna F
BMJ Open
. 2024 Jun;
14(6):e079830.
PMID: 38839380
Introduction: Chronic disease self-management (CDSM) is a vital component of congestive heart failure (CHF) programmes. Recent CHF guidelines have downgraded CDSM programmes citing a lack of gold-standard evidence. This protocol...
8.
Srivastava S, Kumar S, Chinnam S, Srivastava N, Mehta R, Mohanty A, et al.
Travel Med Infect Dis
. 2024 Apr;
59:102723.
PMID: 38640984
No abstract available.
9.
Hariharan R, Cameron J, Menon K, Mesinovic J, Jansons P, Scott D, et al.
Nutr Metab Cardiovasc Dis
. 2024 Jan;
34(2):485-496.
PMID: 38172006
Background And Aims: Type 2 diabetes (T2DM) is a major cause of morbidity and mortality globally. Carnosine, a naturally occurring dipeptide, has anti-inflammatory, antioxidant, and anti-glycating effects, with preliminary evidence...
10.
Iyngkaran P, Usmani W, Hanna F, de Courten M
J Cardiovasc Dev Dis
. 2023 Dec;
10(12).
PMID: 38132654
The healthcare sector generates approximately 30% of all the world's data volume, mostly for record keeping, compliance and regulatory requirements, and patient care. Healthcare data often exist in silos or...